Adial Pharmaceuticals, Inc.
ADIL
$0.3721
$0.00010.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.96M | -2.23M | -2.07M | -2.19M | -2.46M |
| Total Depreciation and Amortization | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 222.80K | 249.80K | 364.00K | 219.30K | 424.90K |
| Change in Net Operating Assets | -13.70K | 393.40K | 252.80K | 278.30K | -114.80K |
| Cash from Operations | -1.75M | -1.59M | -1.45M | -1.69M | -2.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -150.00K | 150.00K | -- | -- | -- |
| Other Investing Activities | 150.00K | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 150.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.30M | 50.60K | 0.00 | 3.61M | 411.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.30M | 50.60K | 0.00 | 3.61M | 411.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.55M | -1.38M | -1.45M | 1.92M | -1.74M |